Kelsie L Thu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Cell Cycle Arrest

Tyrosine Kinase

Endoplasmic Reticulum

Top Venues

Cancer gene therapy

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher Zhang, Benson Z Wu, Caterina Di Ciano-Oliveira, Yin Fang Wu, Sharon S Khavkine Binstock, Isabel Soria-Bretones, Nhu-An Pham, Andrew J Elia, Raj Chari, Wan L Lam, Mark R Bray, Tak W Mak, Ming Sound Tsao, David W Cescon, Kelsie L Thu
Identification of KIFC1 as a putative vulnerability in lung cancers with centrosome amplification. Cancer gene therapy (2024)
Asa P Y Lau, Sharon S Khavkine Binstock, Kelsie L Thu
CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer. Cancers 15 (21) (2023)
Isabel Soria-Bretones, Kelsie L Thu, Jennifer Silvester, Jennifer Cruickshank, Samah El Ghamrasni, Wail Ba-Alawi, Graham C Fletcher, Reza Kiarash, Mitchell J Elliott, Jordan J Chalmers, Andrea C Elia, Albert Cheng, April A N Rose, Mark R Bray, Benjamin Haibe-Kains, Tak Wah Mak, David W Cescon
The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor-resistant ER + breast cancer with mitotic aberrations. Science advances 8 (36) (2022)
Kushal Joshi, Rajiv Sanwal, Kelsie L Thu, Scott S H Tsai, Warren L Lee
Plug and Pop: A 3D-Printed, Modular Platform for Drug Delivery Using Clinical Ultrasound and Microbubbles. Pharmaceutics 14 (11) (2022)